证券记录 · 已归档季度
LNTH
Lantheus Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
16被追踪持有人
-2Δ持有人
29.15M持有股份
$2.39B报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -11.1% ·
股份流向 +3.4% ·
净新建仓位 -12.5%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 6.70K | $264,917 | n/a | −1 |
| Q2 2026 | 130 | +6 | 56.22M | $5.58B | +14 | −7 |
| Q1 2026 | 126 | +6 | 62.19M | $3.90B | +10 | −5 |
| Q4 2025 | 120 | -2 | 60.97M | $3.47B | +2 | −3 |
| Q3 2025 | 20 | +2 | 33.16M | $1.70B | +2 | −1 |
| Q2 2025 | 16 | -2 | 29.15M | $2.39B | +1 | −3 |
| Q1 2025 | 15 | 0 | 7.80M | $761.04M | n/a | n/a |
| Q4 2024 | 15 | 0 | 6.76M | $604.90M | +2 | −2 |
| Q3 2024 | 14 | 0 | 4.84M | $531.32M | +1 | −1 |
| Q2 2024 | 14 | n/a | 5.72M | $459.02M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 8.53M | n/a | $698.55M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 2 | The Vanguard Group ✦ (被动) | 6.84M | n/a | $559.68M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 5.02M | n/a | $410.86M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 4 | State Street Global Advisors ✦ (被动) | 2.56M | -2.9% | $209.45M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (被动) | 1.78M | 0.0% | $145.48M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 1.72M | +89.1% | $140.74M | 0.0% | ▲ Add | 3 | SEC ↗ ×10 |
| 7 | T. Rowe Price ✦ | 1.03M | +3.0% | $84.59M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (被动) | 398.61K | -24.1% | $32.63M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 397.85K | +31.2% | $32.57M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 237.07K | +44.6% | $19.41M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 11 | Capital World Investors ✦ | 194.93K | 新增 | $15.96M | 0.0% | New | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 183.34K | +90.3% | $15.01M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | Fisher Asset Management ✦ | 138.16K | -3.1% | $11.31M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Millennium Management ✦ | 92.21K | -3.6% | $7.55M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 20.29K | -72.7% | $1.65M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 16 | Gotham Asset Management ✦ | 10.87K | -7.8% | $889,573 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Capital World Investors | $15.96M | 0.0% |
已清仓
| Renaissance Technologies | $4.01M | 曾为 0.0% |
| Arrowstreet Capital | $1.11M | 曾为 0.0% |
| Two Sigma Investments | $769,771 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 401 持有人, 70.59M 股份, $5.23B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 13
SC 13G/A: FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 31
SC 13G: VANGUARD PORTFOLIO MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据